Skip to main content
HealthEmergingMediumDeveloping
6.8

Boehringer Ingelheim executive warns of European pharmaceutical supply chain risks

The head of Boehringer Ingelheim's regional branch warns that Europe's lagging research investment compared to the US and China threatens the timely availability of essential medications. The statement highlights structural concerns regarding European pharmaceutical competitiveness and supply chain resilience.

SMEabout 22 hours agoEU, US, CNCredibility 31%View source

Score Breakdown

Mosaic Score6.8
Confidence0.5
Significance0.5
Source credibility0.3

Intelligence Tags

Entities

countrycountryconcept
Source

Related signals

8 found